Location · Rialto, CA
Clinical trials in Rialto, CA
12 recruiting studies have a site in Rialto, and 2 of them accept healthy volunteers.
12 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic Impairment
AstraZeneca
- Location
- Rialto, CA + 1 other US site
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1
A Study to Test How BI 1291583 is Taken up in the Blood of People With and Without Liver Problems
Boehringer Ingelheim
- Location
- Rialto, CA
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Hoffmann-La Roche
- Location
- Rialto, CA + 121 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Hoffmann-La Roche
- Location
- Rialto, CA + 112 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Amgen
- Location
- Rialto, CA + 51 other US sites
- Eligibility basics
- Ages 18–99
- RecruitingPhase 2
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
AbbVie
- Location
- Rialto, CA + 60 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Trial of Inebilizumab in Participants With Autoimmune Hepatitis
Amgen
- Location
- Rialto, CA + 5 other US sites
- Eligibility basics
- Ages 18–74
- RecruitingPhase 3
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Boehringer Ingelheim
- Location
- Rialto, CA + 154 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Boehringer Ingelheim
- Location
- Rialto, CA + 123 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Regeneron Pharmaceuticals
- Location
- Rialto, CA + 34 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
GlaxoSmithKline
- Location
- Rialto, CA + 24 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 1
A Study of Efimosfermin Alfa in Adults With Hepatic Impairment
GlaxoSmithKline
- Location
- Rialto, CA + 2 other US sites
- Eligibility basics
- Ages 18–70